Skinvisible SKVI
OTC SKVI
$0.16 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Operating Expenses (2010 - 2026)

Updated

Skinvisible's Operating Expenses was $117,817 in Q2 2026, down 16.6% from $141,237 a year earlier and down 10.0% from the prior quarter.

Analysis

Skinvisible (SKVI) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Skinvisible's Operating Expenses was $478,981 through Jun 30, 2026, down 22.7% year-over-year; for FY2025, it was $516,315, down 15.3% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $609,589 in FY2024 (+19.4%), $510,375 in FY2023 (-0.5%), $512,920 in FY2022 (+8.7%) and $472,046 in FY2021 (-10.8%).
  • Quarterly Operating Expenses has moved between $105,315 (Q4 2021) and $203,743 (Q4 2024) over five years.
  • Compared with a year earlier, Operating Expenses has declined for five straight quarters, with an average decline of 2.5% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2024 (growth of 43.9%); the worst was Q4 2025 (a decline of 41.5%).
  • Per Business Quant data, SKVI's Operating Expenses in the three quarters before Q2 2026 was $130,938 (Q1 2026), $119,169 (Q4 2025) and $111,057 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 10.12 Bn
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn 10.56 Bn
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 9.70 Bn
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn 18.20 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 6.68 Bn
10 Skinvisible 864,614.86 855,592.86 5,000.00 117,817.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117,817.00
Mar 31, 2026 130,938.00
Dec 31, 2025 119,169.00
Sep 30, 2025 111,057.00
Jun 30, 2025 141,237.00
Mar 31, 2025 144,852.00
Dec 31, 2024 203,743.00
Sep 30, 2024 129,969.00
Jun 30, 2024 147,693.00
Mar 31, 2024 128,184.00
Dec 31, 2023 141,538.00
Sep 30, 2023 118,110.00
Jun 30, 2023 117,823.00
Mar 31, 2023 132,904.00
Dec 31, 2022 122,716.00
Sep 30, 2022 133,183.00
Jun 30, 2022 119,010.00
Mar 31, 2022 138,011.00
Dec 31, 2021 105,315.00
Sep 30, 2021 119,274.00
API Access

Skinvisible Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SKVI&period=max&api_key=YOUR_API_KEY